Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MICALL2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA555240
Description
Immunogen sequence: DVCDNWLRPE PPGQEARVQS WKEEEKKPHL QGKPGRPLSP ANVPALPGET VTSPVRLHPD YLSPEEIQRQ LQDIERRLDA LELRGVELEK RL Highest antigen sequence identity to the following orthologs: Mouse - 59%, Rat - 57%.
Effector of small Rab GTPases which is involved in junctional complexes assembly through the regulation of cell adhesion molecules transport to the plasma membrane and actin cytoskeleton reorganization. Regulates the endocytic recycling of occludins, claudins and E-cadherin to the plasma membrane and may thereby regulate the establishment of tight junctions and adherens junctions. In parallel, may regulate actin cytoskeleton reorganization directly through interaction with F-actin or indirectly through actinins and filamins. Most probably involved in the processes of epithelial cell differentiation, cell spreading and neurite outgrowth. [UniProt].
Specifications
MICALL2 | |
Polyclonal | |
Unconjugated | |
MICALL2 | |
JRAB; Junctional Rab13-binding protein; MICAL like 2; MICALL2; MICAL-L2; MICAL-like 2; MICAL-like protein 2; milk2; Molecule interacting with CasL-like 2 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
79778 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
1.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q8IY33 | |
MICALL2 | |
Recombinant protein corresponding to Human MICALL2. Recombinant protein control fragment (Product #RP-92856). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction